May 23, 2023
Sponsored By:
Speakers
Session Description
<div class="ag87-crtemvc-hsbk"><div class="css-vsf5of"><p class="carina-rte-public-DraftStyleDefault-block"><span style="color: rgb(29,28,29);">The public markets play an important role in funding and validating synthetic biology companies. As the industry matures, what power do public markets have to make or break synthetic biology? How can large companies navigate the current market conditions as they approach going their IPO? What hallmarks of investment-worthy public companies do we need to take into account?</span></p></div></div>